WILLIAM GUY: Open Payments
NPI 1295748101 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169,194 in 206 payments from 7 companies in 2025. Trend: 2023 $69,779 · 2024 $133,898 · 2025 $169,194
Speaker / faculty: $129,013Travel & lodging: $20,371Honoraria: $11,800Consulting: $4,080Food & beverage: $3,922Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 154 | $121,154 |
| Teva Pharmaceuticals USA, Inc. | 12 | $18,968 |
| Axsome Therapeutics, Inc. | 18 | $14,910 |
| Otsuka America Pharmaceutical, Inc. | 14 | $8,004 |
| Vanda Pharmaceuticals Inc. | 6 | $6,106 |
| Alkermes, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: CAPLYTA, AUSTEDO XR, Auvelity, REXULTI, FANAPT, ARISTADA, COBENFY, ABILIFY MAINTENA.
Industry payments across MI — which companies pay providers there.
